Predictive Oncology Inc. Gains 50.89%

Predictive Oncology Inc. (POAI:NASDAQ) jumped higher at $1.69, a gain of 50.9%. On Tue, Mar 25, 2025, POAI:NASDAQ hit a New 2-Week High of $1.69. The stock appeared on our News Catalysts scanner on Tue, Mar 25, 2025 at 10:18 AM in the 'BIOTECH' category. From Tue, Mar 11, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Mar 25, 2025 at $2.6 with a volume of 152M+.
About Predictive Oncology Inc. (POAI:NASDAQ)
Precision Therapeutics Inc functions in the healthcare domain. It is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed of.
Top 10 Gainers:
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 2042.86%
- Tenon Medical Inc. (TNON:NASDAQ), 283.4%
- Dominion Energy Midstream Partners, LP (DM:NYSE), 99.12%
- Golden Heaven Group Holdings Ltd. (GDHG:NASDAQ), 94.39%
- DatChat Inc. (DATS:NASDAQ), 75%
- Hempacco Co. Inc. (HPCO:NASDAQ), 53.85%
- Predictive Oncology Inc. (POAI:NASDAQ), 50.89%
- Raytech Holding Limited (RAY:NASDAQ), 49.23%
- Zhengye Biotechnology Holding Limited (ZYBT:NASDAQ), 41.38%
- Forte Biosciences Inc. (FBRX:NASDAQ), 34.65%